Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler

Stroke

Volumn 35, Issue 9, 2004, Pages 2140-2144

  Anzola, Gian Paolo ^a   Morandi, E ^a   Casilli, F ^b   Onorato, E ^b  

^a S Orsola Hospital   (Italy)

^b Humanitas Gavazzeni Hospital   (Italy)

Author keywords

Foramen ovale, patent; Stroke

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PARAMETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VALSALVA MANEUVER;

ADULT; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INTRACRANIAL EMBOLISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NICKEL; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; SCOTOMA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VALSALVA MANEUVER;

EID: 4344682856     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000137764.07815.de     Document Type: Article

References (27)

1. Anzola GP, Zavarisz P, Morandi E, Rozzini L, Parrinello G. Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. Eur J Neurol. 2003;10:129-135.
2. Mas JL, Arquizan C, Lanny C, Zuber M, Cabanes L, Derumeaux G, Coste J; for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm or both. N Engl J Med 2001;345:1740-1746.
3. De Castro S, Cartoni D, Fiorelli M, Rasura M, Auzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Paudian NG. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407-2413.
4. Nedeltchev K, Arnold M, Wahl A, Sturzenegger M, Vella EE, Windecker S, Meier B, Mattle HP. Outcome of patient with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry. 2002;72:347-350.
5. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale. Patent foramen ovale in cryptogenic stroke study. Circulation. 2002;105:2625-2631.
6. Bridges WD, Hellenbrand W, Lakson L, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86:1902-1908.
7. Sievert H, Babic UU, Hausdorf G, Scgneider M, Hopp HW, Pfeiffer D, Pfisterer M, Friedli B, Urban P. Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multiinstitutional European trial). Am J Cardiol. 1998;82:1405-1413.
8. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli F, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2000;101:893-898.
9. Wahl A, Meier B, Haxel B, Nedeltchev K, Arnold M, Eicher E, Sturzenegger M, Seiler C, Mattle HP, Windecker S. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology. 2001;57:1330-1332.
10. Butera G, Bini MR, Chessa M, Bedogni F, Onofri M, Carminati M. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J. 2001;2:115-118.
11. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism. Single-center experience. Circulation. 2002;105:2845-2848.
12. Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King MEE, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106:1121-1126.
13. Braun MU, Fassbender D, Schoen SP, Haass M, Scraeder R, Scoltz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 2002;39:2019-2025.
14. Du ZD, Cao QL, Joseph A, Koenig P, Heischmidt M, Waight DJ, Rhodes J, Brorson J, Hijazi ZM. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events. Catheter Cardiovasc Interv. 2002;55:189-194.
15. Khairy P, O'Donnell C, Landzberg MI. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli. A systematic review. Ann Intern Med. 2003;139:753-760.
16. Kay JD, O'Laughlin MP, Ito K, Wang A, Bashore TM, Harrison JK. Five-year clinical and echocardiographic evaluation of the Das AngelWings atrial septal occluder. Am Heart J. 2004;147:361-368.
17. Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchev K, Mattle H, Seiler C, Meier B. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart. 2004;90:186-190.
18. Khositseth A, Cabalka AK, Sweeney JP, Fortuin FD, Reeder GS, Connolly HM, Hagler DJ. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovate in patients with presumed paradoxical embolism. Mayo Clin Proc. 2004;79:35-41.
19. Serena J, Segura T, Perez-Ayuso MJ, Bassaganyas J, Molins A, Davalos A. The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke. 1998;29:1322-1328.
20. Jauss M, Zanette E. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 2000;10:6:490-496.
21. Onorato E, Melzi G, Casilli F, Pedon L, Rigatelli G, Carrozza A, Maiolino P, Zanchetta M, Morandi E, Angeli S, Anzola GP. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Interven Cardiol. 2003;16:43-50.
22. Kerut EK, Norfleet WT, Plotnick GD, Giles T. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38:613-623.
23. Schuchlenz HW, Wehis W, Beitzke A, Stein JI, Gamillscheg A, Rehak P. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke. 2002;33:293-296.
24. Droste DW, Silling K, Stypmann J, Grude M, Kemeny V, Wichter T, Kuhne K, Ringelstein EB. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Time window and threshold in microbubble numbers. Stroke. 2000;31:1640-1645.
25. Berthet K, Lavergne T, Cohen A. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke. 2000;31:398-403.
26. Rouesnel P, Babuty D, Fauchier L, Saudeau D, Hurreesing R, Cosnay P, Garnier LF. Comparative study of atrial vulnerability in patients with unexplained ischemic stroke or lone atrial paroxysmal fibrillation. Ann Cardiol Angeiol (Paris). 2003;52:220-225.
27. Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am Heart J. 2003;145:737-741.